TipRanks
Go Ultimate55% OFF

Kidswell Bio Corporation (4584) Financial Statements

0 Followers

Kidswell Bio Corporation Financial Overview

Kidswell Bio Corporation's market cap is currently ¥7.59B. The company's EPS TTM is ¥-7.60; its P/E ratio is -17.76; Kidswell Bio Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 6.59B¥ 5.08B¥ 2.43B¥ 2.78B¥ 1.57B
Gross Profit¥ 1.75B¥ 1.64B¥ 1.04B¥ 1.53B¥ 1.02B
Operating Income¥ -138.51M¥ 27.88M¥ -1.34B¥ -550.93M¥ -651.14M
EBITDA¥ -138.26M¥ 116.26M¥ -1.38B¥ -620.45M¥ -531.89M
Net Income¥ -413.99M¥ -21.14M¥ -1.42B¥ -657.43M¥ -550.86M
Balance Sheet
Cash & Short-Term Investments¥ 3.29B¥ 3.00B¥ 2.23B¥ 1.07B¥ 1.16B
Total Assets¥ 6.09B¥ 7.01B¥ 5.09B¥ 3.89B¥ 3.47B
Total Debt¥ 2.55B¥ 1.84B¥ 2.58B¥ 1.95B¥ 700.00M
Net Debt¥ -744.92M¥ -1.16B¥ 343.59M¥ 882.84M¥ -460.93M
Total Liabilities¥ 4.43B¥ 5.60B¥ 4.25B¥ 2.66B¥ 1.77B
Stockholders' Equity¥ 1.65B¥ 1.41B¥ 831.47M¥ 1.23B¥ 1.70B
Cash Flow
Free Cash Flow¥ -1.11B¥ 930.26M¥ -453.63M¥ -1.42B¥ -1.17B
Operating Cash Flow¥ -1.09B¥ 936.71M¥ -453.63M¥ -1.42B¥ -1.17B
Investing Cash Flow¥ -12.62M¥ 65.08M¥ 0.00¥ -28.82M¥ 526.51M
Financing Cash Flow¥ 1.40B¥ -240.06M¥ 1.62B¥ 1.36B¥ 369.08M

Currency in JPY

Kidswell Bio Corporation Earnings and Revenue History

-16B-8B08B-750 %-500 %-250 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Kidswell Bio Corporation Liabilities to Assets

02.5B5B7.5B0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Kidswell Bio Corporation Cash Flow

-2B-1B01B2B201720182019202020212022202320242025OperatingInvestingFinancing

Kidswell Bio Corporation Forecast EPS vs Actual EPS

-8-6-4-20246Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26EPS EstimateBeatMiss